CooperSurgical Inc ART Media - Procedural steps and scientific information after initial consultation (archive)

Origio - Procedural steps and scientific information after initial consultation (archive)

Human medicines European public assessment report (EPAR): Supemtek Tetra (previously Supemtek), quadrivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 16/11/2020, Revision: 10, Status: Authorised

Questions and answers (Q&As) on the external guidance of Policy 0070 on clinical data publication (CDP)

Marketing authorisation application (MAA) - pre-submission interactions form

New fee regulation: General questions and answers for all applicants

5th Veterinary Big Data Stakeholder Forum, Online, European Medicines Agency, Amsterdam, the Netherlands, from 10 November 2025, 10:00 (CET) to 10 November 2025, 15:00 (CET)

Anti-t lymphocyte immunoglobulin for human use, rabbit : List of nationally authorised medicinal products - PSUSA/00010252/202406

Human medicines European public assessment report (EPAR): Incruse Ellipta (previously Incruse), umeclidinium bromide, Date of authorisation: 28/04/2014, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Date of authorisation: 23/04/2025, Revision: 1, Status: Authorised